出处
《中国自然医学杂志》
CAS
2007年第5期446-449,共4页
Chinese Journal of Natural Medicine
基金
国家自然科学基金资助项目(30471526)
参考文献42
-
1[1]Raniglione MC,Snider DE,Kochi A.Global epidemiolog y of tuberculosis:morbidity and mortality of a worldwide epidemic.JAMA,1995,273:220-226.
-
2[2]Dye C,Scheele S,Dolin P,et al.Consensus statement.Global burden of tuberculosis:estimated incidence,prevalence,and mortality by country.WHO Global Surveillance and Monitoring Project.JAMA,1999,28 2:677-686.
-
3[3]Treatment of tuberculosis:guidelines for national programs.WHO.2003 (document WHO/CDS/TB/2003.313).
-
4[4]Bloom BR,Murray CJ.Tuberculosis:Commentary on aremergent killer.Science,1992,257:1055-1064.
-
5[5]Global tuberculosis control.WHO Report 2000.Geneva,WHO 2000 (document WHO/CDS/TB/2000.275).
-
6[6]Busillo CP,Lessnau KD,Sanjana V,et al.Multidrug r esistant Mycobacterium tuberculosis in patients with human immunodeficiency virus infection.Chest,1992,102:797-801.
-
7[8]Schatz A,Waksman SA.Effect of streptomycin and other antibiotic substances upon mycobacterium tuberculosis and related organism.Proc Soc Exp Bio Medical,1944,57:244-248.
-
8[9]Klein M,Kimmelman LJ.The role of spontaneous variants in the acquisition of streptomycin resistance by the shigellae.J Bacteriol,19 46,52:471-479.
-
9[10]Wimberly BT,Brodersen DE,Clemons WM,et al.Structure of the 30S ribosomal subunit.Nature,2000,407:327-339.
-
10[11]Carter AP,Clemons WM,Brodersen,DE,et al.Functional insights from the structure of the 30S ribosomal subunit and its interaction with a ntibiotics.Nature,2000,407:340-348.
二级参考文献32
-
1乐军,曾而良,谢建平,李瑶,梁莉,王洪海.中国耐多药结核分枝杆菌临床分离株rpoB基因突变特点[J].Acta Genetica Sinica,2004,31(12):1332-1336. 被引量:23
-
2[1]Cole ST,Brosch R,Parkhill J,Garnier T,Churcher C,Harris D,Gordon S V,Eiglmeier K,Gas S,Barry C E 3rd,Tekaia F,Badcock K,Basham D,Brown D,Chillingworth T,Connor R,Davies R,Devlin K,Feltwell T,Gentles S,Hamlin N,Holroyd S,Hornsby T,Jagels K,Barrell B G.Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.Nature,1998,11;393(6685):537~544.
-
3[2]Cole S T,Barrell B G.Analysis of the genome of Mycobacterium tuberculosis H37Rv.Novartis Found Symp,1998,217:160~172;discussion 172~177.
-
4[3]Ruiz P,Rodriguez-Cano F,Zerolo F J,Casal M.Casal M.Investigation of the in vitro activity of streptomycin against Mycobacterium tuberculosis.Microb Drug Resist,2002,8(2):147~149.
-
5[4]Ramaswamy S,Musser J M.Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis:1998 update,Tuber Lung Dis,1998,79(1):3~29.
-
6[5]Busse H J,Wostmann C,Bakker E P.The bactericidal action of streptomycin:membrane permeabilization caused by the insertion of mistranslated proteins into the cytoplasmic membrane of Escherichia coli and subsequent caging of the antibiotic inside the cells due to degradation of these proteins.J Gen Microbiol,1992,138:551~561.
-
7[6]Dobner P,Bretzel G,Rusch-Gerdes S,Feldmann K,Rifai M,Loscher T,Rinder H.Geographic variation of the predictive values of genomic mutations associated with streptomycin resistance in Mycobacterium tuberculosis.Mol Cell Probes,1997,11(2):123~126.
-
8[7]Ohno H,Koga H,Kohno S.Multidrug-resistant tuberculosis.2.Mechanisms of drug-resistance in Mycobacterium tuberculosis--genetic mechanisms of drug-resistance.Kekkaku,1998,73(11):657~663.
-
9[8]Mieskes K T,Rusch-Gerdes S,Truffot-Pernot C,Feldmann K,Tortoli E,Casal M,Loscher T,Rinder H.Rapid,simple,and culture-independent detection of rpsL codon 43 mutations that are highly predictive of streptomycin resistance in Mycobacterium tuberculosis.Am J Trop Med Hyg,2000,63(1~2):56~60.
-
10[10]Eisenach K D,Cave M D,Bates J H,Crawford J T.Polymerase chain reaction amplification of a repetitive DNA sequence specific for Mycobacterium tuberculosis.J Infect Dis,1990,161(5):977~981.
共引文献30
-
1魏淑贞,陈求扬,万康林,林淑芳,梁庆福,赵永,林建,郑金凤.福建省46株耐多药结核分枝杆菌rpoB基因突变特征分析[J].中国人兽共患病学报,2012,28(9):913-916. 被引量:2
-
2宋艳斌,马文丽,郑文岭.结核分支杆菌rpsL基因突变的快速检测[J].广东医学,2005,26(4):469-470. 被引量:2
-
3王莹,谢建平,胡昌华,张文宏.耐药结核分枝杆菌链霉素耐药基因的分子流行病学研究及其快速检测[J].中国感染与化疗杂志,2006,6(5):313-316. 被引量:3
-
4周劲松,陈建庭,吴雪琼,李洪敏.脊柱结核耐药性检测及耐药基因PCR-SSCP分析的应用价值[J].临床骨科杂志,2006,9(5):399-402. 被引量:4
-
5黄振宇,范学工.210株结核分枝杆菌利福平耐药基因rpoB突变特征研究[J].中国人兽共患病学报,2007,23(6):548-551. 被引量:15
-
6郑瑞娟,王洁,秦莲花,陆俊梅,胡忠义.焦磷酸测序技术在利福平rpoB基因突变检测中的应用评价[J].中华预防医学杂志,2008,42(2):77-80. 被引量:2
-
7朱敏,范玉美,盛国平,李君,李锋.浙江省耐药结核分枝杆菌katG、rpoB、embB基因突变特点研究[J].医学研究杂志,2008,37(3):26-29. 被引量:14
-
8邵明明,薛欣,楚雍烈,寻萌,宋娟,曹春霞,邱奕.结核分枝杆菌链霉素耐药基因rpsL的检测[J].中国病原生物学杂志,2008,3(9):651-653. 被引量:3
-
9刘坦业.严重耐多药结核病的流行与控制[J].海峡预防医学杂志,2009,15(1):1-3.
-
10石小华,景奉香,胡忠义,崔振玲,赵建龙,朱蕾.DNA芯片快速检测结核分枝杆菌对链霉素和乙胺丁醇的耐药性方法的建立[J].南京医科大学学报(自然科学版),2009,29(4):435-440. 被引量:1
同被引文献4
-
1李晓杰,王洪生,吴勤学,崔盘根,刘训荃.PCR-RFLP检测皮肤分枝杆菌[J].中华皮肤科杂志,2005,38(9):533-535. 被引量:3
-
2结核病诊断细菌学检验规程[J].中国防痨杂志,1996,18(2):80-85. 被引量:78
-
3结核病诊断细菌学检验规程[J].中国防痨杂志,1996,18(1):28-31. 被引量:799
-
4王洪生,吴勤学,刘琦.麻风病患者皮损中分离出的分枝杆菌的分子鉴定[J].中国麻风皮肤病杂志,2007,23(5):382-383. 被引量:1
引证文献1
-
1张彩萍,季江,林麟,杨毅琴,崔盘根,冯雨苗,岳晓玉,赵亮,曾学思,吴勤学,王洪生.16例皮肤结核分离菌株药敏试验分析[J].中华皮肤科杂志,2009,42(6):371-373. 被引量:1
-
1蒋毅,万康林,阚飚.结核病的细胞免疫研究进展[J].医学研究杂志,2012,41(6):11-14. 被引量:5
-
2中华医学会第三届全国睡眠呼吸疾病学术会议第一轮通知[J].中国呼吸与危重监护杂志,2012,11(1):51-51.
-
3中华医学会第三届全国睡眠呼吸疾病学术会议第一轮通知[J].中国呼吸与危重监护杂志,2012,11(2):175-175.
-
4胡耀文,楼亚玲,赵志伟.呼吸道感染革兰阴性杆菌的分布及药敏分析[J].中国乡村医药,2010,17(4):55-56.
-
5方妍彤.注意缺陷多动障碍认知水平比较研究[J].浙江预防医学,2009,21(9):74-74.
-
6中华医学会第三届全国睡眠呼吸疾病学术会议第一轮通知[J].中国呼吸与危重监护杂志,2012,11(3):299-299.
-
7杜育达,鲁继荣,张桂芳,付文永.吉林省5地区0-14岁儿童出生缺陷的研究[J].中国优生与遗传杂志,1999,7(1):87-88. 被引量:2
-
8骆科文,张廷梅,张晓君,赵高仁,陈永立.结核分枝杆菌4382株耐药结果分析[J].贵州医药,2006,30(9):847-848. 被引量:2
-
9胡婕,陈香美.干细胞治疗肾脏病的研究进展[J].中华肾病研究电子杂志,2012,1(2):36-38.
-
10Antonios TF,Nama V,Wang D,Manyonda IT,罗冬梅.先兆子痫时的微血管重构:检测毛细血管的稀疏程度可准确并独立预测先兆子痫[J].中华高血压杂志,2013,21(12):1198-1198. 被引量:1